A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/10/2009	US20090306018 Skin conditioner
12/10/2009	US20090306017 Methods and compositions for modulation of innate immunity
12/10/2009	US20090306016 Fatty acid amide hydrolase inhibitors
12/10/2009	US20090306015 Pharmaceutical compositions and methods of use of highly lipophilic sulfhydryl compounds
12/10/2009	US20090306014 C-10 carbamates of taxanes
12/10/2009	US20090306013 Drugs and Food Products for Hypophosphoric Normo-,Hyper-and Hypoproteic Diets, and Hypophosphoric Beverages
12/10/2009	US20090306012 Therapeutic protocols
12/10/2009	US20090306010 P1-(2'-deoxycytidine 5'-)p4-(uridine 5'-)tetraphosphate, tetra-(alkali metal) salt, for treating disorders
12/10/2009	US20090306009 Modulation of the P2Y2 Receptor Pathway
12/10/2009	US20090306008 3'-ethynylcytidine derivative
12/10/2009	US20090306007 Nucleosides with antiviral and anticancer activity
12/10/2009	US20090306006 Use of nicotinic acid adenine dinucleotide phosphate or derivative thereof as agent for treating type-2 diabetes
12/10/2009	US20090306005 Compounds and methods for modulating expression of pcsk9
12/10/2009	US20090306004 Grafted macromolecular conjugates of doxorubicin with anticancer activity and method of their preparation
12/10/2009	US20090306002 Iron metabolism-improving agent
12/10/2009	US20090306001 Novel amphiphilic derivatives of alpha-c-phenyl-n-tert-butylnitrone
12/10/2009	US20090306000 Tanaproget derivatives, metabolites, and uses thereof
12/10/2009	US20090305999 Utilization of hypertension/hypercardia-preventing effect of d-allose
12/10/2009	US20090305998 Hsp90 inhibitors
12/10/2009	US20090305997 Use of a galactose-derived c-glycoside compound as an agent for activating and regulating cutaneous immunity
12/10/2009	US20090305996 Use of non-digestable sacharides for giving an infant the best start after birth
12/10/2009	US20090305995 Agonists and antagonists of the somatostatin receptor
12/10/2009	US20090305992 Use of an interleukin 1 receptor antagonist and/or pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes
12/10/2009	US20090305991 33 Human Secreted Proteins
12/10/2009	US20090305989 Composition and method for potentiating drugs
12/10/2009	US20090305979 Compositions comprising hpv polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer
12/10/2009	US20090305977 Method for treating peripheral arterial disease with zinc finger proteins
12/10/2009	US20090305972 Novel cancer-associated antigen
12/10/2009	US20090305968 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway
12/10/2009	US20090305957 Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction
12/10/2009	US20090305953 Dalbavancin compositions for treatment of bacterial infections
12/10/2009	US20090305948 Branched Polyamino Acids Functionalized with Hydrophobic Groups, and Applications Thereof Particularly Therapeutic Applications
12/10/2009	US20090305343 Method For Expressing Polypeptides In Eukaryotic Cells Using Alternative Splicing
12/10/2009	US20090305225 Inhibition of Creatine Uptake to Promote Weight Loss
12/10/2009	US20090304832 Treatment of Parasitic Infections in Humans and Animals
12/10/2009	US20090304828 Pharmaceutical Composition and Functional Food for Suppressing and Relieving Itching and Inflammation
12/10/2009	US20090304827 Combinations of Ingredients Having Synergistic Anti-Inflammatory Effects
12/10/2009	US20090304826 Method and composition for dermatoses
12/10/2009	US20090304825 Estrogenic extracts for use in treating vaginal and vulvar atrophy
12/10/2009	US20090304824 Rapid-Melt Compositions, Methods of Making Same and Methods of Using Same
12/10/2009	US20090304823 Nutritional compositions for promotion of bone growth and maintenance of bone health and methods regarding same
12/10/2009	US20090304821 Pharmaceutical Combination
12/10/2009	US20090304820 Solubilized benzoyl peroxide topical drug formulation for the treatment of acne
12/10/2009	US20090304816 Method and composition for treating and diagnosing restless legs syndrome
12/10/2009	US20090304815 Method of treatment for muscular dystrophy
12/10/2009	US20090304813 Virucidal compositions and uses
12/10/2009	US20090304812 Topical Pharmaceutical Compositions
12/10/2009	US20090304806 Pharmaceutical Compositions
12/10/2009	US20090304801 Aerosol and injectable formulations of nanoparticulate benzodiazepine
12/10/2009	US20090304798 Methods and compositions for therapeutic use of RNA interference
12/10/2009	US20090304797 Process for the Preparation of Micronized Valsartan
12/10/2009	US20090304794 Controlled release formulations of pramipexole
12/10/2009	US20090304793 Sustained release opioid formulations and methods of use
12/10/2009	US20090304792 Granule and orally disintegrating tablet comprising oxycodone
12/10/2009	US20090304791 Solid oral forms of ebastine
12/10/2009	US20090304790 Controlled release pharmaceutical compositions comprising a fumaric acid ester
12/10/2009	US20090304789 Novel topiramate compositions and an escalating dosing strategy for treating obesity and related disorders
12/10/2009	US20090304786 Stable Dosage Forms of an Antidepressant
12/10/2009	US20090304785 Escalating dosing regimen for effecting weight loss and treating obesity
12/10/2009	US20090304784 Seamless capsules containing high amounts of polyunsaturated fatty acids and a flavouring component
12/10/2009	US20090304782 Topical Ibuprofen Formulation
12/10/2009	US20090304776 Transmucosal delivery of therapeutic agents and methods of use thereof
12/10/2009	US20090304773 Surgical adhesive and uses therefore
12/10/2009	US20090304771 Local Delivery System for the Chemotherapeutic Drug Paclitaxel
12/10/2009	US20090304770 Polymer
12/10/2009	US20090304769 Methods for identifying agents and their use for the prevention of restenosis
12/10/2009	US20090304758 Formulations of lipoic acid and hyaluroinc acid and/or the derivatives thereof in the pharmaceutical and cosmetic fields
12/10/2009	US20090304755 Pharmaceutical formulation of losartan
12/10/2009	US20090304750 Novel prime-boost combinations of attenuated mycobacterium
12/10/2009	US20090304746 Inducing cellar immune responses to hepatitis C virus using peptide and nucleic acid compositions
12/10/2009	US20090304744 Methods of enhancing immune response in the intradermal compartment and compounds useful thereof
12/10/2009	US20090304734 Immunogens for meningitidis-a vaccines
12/10/2009	US20090304732 Cryptosporidium Hominis Genes and Gene Products for Chemotherapeutic, Immunoprophylactic and Diagnostic Applications
12/10/2009	US20090304722 Chlamydia trachomatis antigens for vaccine and diagnostic use
12/10/2009	US20090304720 Active Agent-Loaded Nanoparticles Based On Hydrophilic Proteins
12/10/2009	US20090304714 IKKi Inhibitor Therapies and Screening Methods, and Related IKKi Diagnostics
12/10/2009	US20090304708 Preparation for the Prevention and/or Treatment of a Tissue Change of Mesenchymal Origin
12/10/2009	US20090304692 Triazine compounds as pi3 kinase and mtor inhibitors
12/10/2009	US20090304691 Antagonists of bmp9, bmp10, alk1 and other alk1 ligands, and uses thereof
12/10/2009	US20090304683 Soluble Fragments of The Sars-Cov Spike Glycoprotein
12/10/2009	US20090304680 Diagnosis and treatment of kawasaki disease
12/10/2009	US20090304678 Means for Inhibiting the Expression of Protein Kinase 3
12/10/2009	US20090304676 Compositions and methods for enhancing cognitive function
12/10/2009	US20090304675 Method of modulation of mullerian inhibitory substance (mis) receptor for the treatment of neurodegenerative diseases
12/10/2009	US20090304664 Modulators of alpha-synuclein toxicity
12/10/2009	US20090304663 Use of gsk-3 inhibitors for the treatment of prostate cancer
12/10/2009	US20090304651 Insulin-Like Growth Factor II (IGF-II) Binding Factors
12/10/2009	US20090304648 Mast Cell Stabilizers to Prevent or Treat Laminitis
12/10/2009	US20090304641 Methods and Compositions for Regulating Gene Expression
12/10/2009	US20090304640 Transfection of Collagen-Producing Cells
12/10/2009	US20090304637 Recombinant mycobacterium strain expressing a mycobacterial fap protein under the control of a promoter active under hypoxia and its application for cancer therapy
12/10/2009	US20090304636 Stem Cell Factor Therapy for Tissue Injury
12/10/2009	US20090304635 Methods for generating new hair follicles, treating baldness, and hair removal
12/10/2009	US20090304634 Novel Combinations
12/10/2009	US20090304632 HETEROCYCLIC NF-kB INHIBITORS
12/10/2009	US20090304631 Hepatitis c serine protease inhibitors and uses therefor
12/10/2009	US20090304630 Treating severe and acute viral infections
12/10/2009	US20090304625 Modulators of cardiac cell hypertrophy and hyperplasia
12/10/2009	US20090304623 Once A Day Formulation for Phosphate Binders
12/10/2009	US20090304615 Tricyclic compounds as melanogenesis modifiers and uses thereof

1 ... 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 2485 ... 7860